Sulaimani Dental Journal (SDJ) is committed to maintaining the highest standards of research ethics, participant protection, scientific integrity, and responsible data sharing. The journal expects authors, reviewers, and editors to comply with internationally recognized ethical and publication standards, including the World Medical Association (WMA) Declaration of Helsinki, the recommendations of the International Committee of Medical Journal Editors (ICMJE), and the Core Practices of the Committee on Publication Ethics (COPE).
1. Ethical Compliance
All research submitted to Sulaimani Dental Journal must be conducted in accordance with applicable ethical standards, institutional requirements, and relevant national and international regulations. Authors are responsible for obtaining the necessary ethical approvals before commencing research, where required.
2. Human and Animal Research Ethics
Human Research: Research involving human participants, human tissues, or identifiable human data must receive prior approval from an appropriately constituted Institutional Review Board (IRB) or Research Ethics Committee, where required. Informed consent must be obtained from participants or their legally authorized representatives, as applicable. Where an ethics committee has formally waived the requirement for ethical approval or informed consent, authors must provide the relevant justification and documentation.
Animal Research: Research involving animals must comply with applicable animal welfare regulations and recognized ethical standards. Authors should follow the ARRIVE 2.0 guidelines and the principles of Replacement, Reduction, and Refinement (3Rs). Approval from the relevant institutional animal ethics committee must be obtained before the research begins, where required.
3. Informed Consent and Patient Confidentiality
Authors must protect the privacy, dignity, and confidentiality of research participants and patients. Identifiable personal information, including names, initials, hospital or patient record numbers, and other identifying details, must not appear in submitted manuscripts or supplementary materials.
Clinical photographs, radiographs, CBCT images, and case descriptions must be appropriately anonymized. Written informed consent for publication must be obtained from the patient or legally authorized representative whenever an individual may be identifiable from the published material.
Consent to participate in research and consent to publish identifiable information are separate requirements and must be addressed accordingly.
Research datasets shared alongside published articles must also be appropriately de-identified. Authors must consider indirect identifiers, including exact dates, rare diagnoses, small demographic groups, and identifiable clinical or radiographic images. Where adequate de-identification is not possible, data must not be made publicly available and should only be shared through an appropriate controlled-access mechanism, where ethically and legally permissible.
4. Conflict of Interest and Research Integrity
Authors, reviewers, and editors must disclose financial, institutional, personal, or professional relationships that could influence, or reasonably be perceived to influence, their work or editorial decisions.
All submitted manuscripts must be original and must not contain plagiarism, fabrication, falsification, inappropriate image manipulation, or redundant publication. Sulaimani Dental Journal reserves the right to screen submissions for plagiarism and investigate potential research or publication misconduct in accordance with COPE guidance.
5. Ethical Approval and Research Declarations
Manuscripts involving human participants, animals, or other research requiring ethical oversight must include an appropriate ethical approval statement in the Methods section.
The statement should identify:
- The name of the approving Research Ethics Committee or Institutional Review Board.
- The official approval or reference number and approval date.
- Confirmation of informed consent, where applicable.
- Any formal exemption or waiver, including the responsible committee and justification.
- Compliance with the relevant ethical guidelines.
For human research, authors should identify compliance with the WMA Declaration of Helsinki. For animal research, authors should identify the applicable animal welfare standards and reporting guidelines.
Clinical trials must include prospective registration details, including the registry name, registration number, and registration URL.
A Data Availability Statement must also be included in every manuscript, as described below.
6. Research Data Sharing and Availability
The journal supports transparency, reproducibility, and responsible research data sharing. Authors are encouraged to make the data supporting their findings available in accordance with the principle that research data should be as open as possible and as restricted as necessary.
6.1. Scope
This policy applies to original research articles, clinical trials, observational and epidemiological studies, laboratory and in vitro investigations, animal studies, systematic reviews and meta-analyses, and case reports or case series involving original datasets.
6.2. Mandatory Data Availability Statement
All manuscripts must include a Data Availability Statement after the Conclusion and immediately before the References.
The statement must clearly indicate one of the following:
Sample Data Availability Statements for authors:
6.3. Data Sharing and Repositories
Authors are encouraged to deposit supporting datasets in recognized repositories that provide persistent identifiers, preferably DOIs. Examples include Zenodo, Figshare, Dryad, Mendeley Data, and the Open Science Framework (OSF).
Where appropriate, shared materials may include:
- De-identified datasets supporting the reported findings.
- Data dictionaries and codebooks.
- Questionnaires and data collection instruments.
- Statistical analysis code and scripts.
- Relevant laboratory measurements and research outputs.
Datasets must be accompanied by sufficient documentation to facilitate interpretation and reuse. Deposited datasets should be cited in the manuscript's reference list.
6.4. Clinical Trials and Systematic Reviews
Clinical trials must be prospectively registered in a publicly accessible registry recognized by WHO or accepted under applicable ICMJE requirements. Authors should provide the registration details in the manuscript.
Authors are encouraged to share de-identified individual participant data, study protocols, and statistical analysis plans when ethically and legally permissible.
Systematic reviews and meta-analyses should provide complete search strategies, extracted study data, and risk-of-bias assessments as supplementary materials or through an appropriate repository. Prospective protocol registration, such as PROSPERO registration where eligible, is encouraged.
6.5. Privacy, Ethical Restrictions, and Exceptions
Data sharing must not compromise participant confidentiality, violate informed consent agreements, breach ethical approval conditions, or contravene applicable data protection laws.
Exceptions to public data sharing are permitted when justified by ethical, legal, privacy, contractual, commercial, security, or third-party ownership restrictions.
Authors must explain any restrictions in their Data Availability Statement. The Editor-in-Chief may request supporting documentation when necessary.
Legitimate restrictions on public data sharing will not, in themselves, adversely affect editorial decisions.
6.6. Editorial Verification and Peer Review
Authors must provide relevant underlying data, original images, or analytical materials to the editors and peer reviewers upon reasonable request when necessary to assess the validity and integrity of the submitted research.
Reviewers must treat all unpublished research data and materials as confidential and must not retain, distribute, or reuse them outside the peer-review process.
6.7. Data Licensing and Retention
Authors are encouraged to apply appropriate standard open licences to datasets deposited in public repositories, such as CC0 or CC BY 4.0, where legally and ethically permissible.
Supplementary materials published by Sulaimani Dental Journal are subject to the journal's applicable licensing terms, unless otherwise stated.
Authors must retain underlying research data, consent documentation, and relevant research records for at least five years after publication, or longer where required by institutional, funding, or applicable legal requirements.
7. Non-Compliance and Policy Review
Failure to comply with this policy may result in editorial action, including manuscript rejection, requests for clarification or supporting documentation, correction, publication of an Expression of Concern, or retraction, as appropriate and in accordance with COPE guidance.
Where necessary, the journal may refer serious concerns to the relevant institution or funding organization.
This policy is reviewed periodically by the Editorial Board to maintain consistency with internationally recognized research ethics and publication standards.